Energy, Productivity & Well-Being

As signs and symptoms of aging appear—from body composition, fatigue and libido loss to bone density, cognitive function and disturbed sleep—a patient’s quality of life wanes. Consequently, energy and overall productivity diminishes, resulting in a deflated sense of well-being. Even Corporate America has felt the impact of these patients’ sub par performance on the job.

We now know how to remove the signs and symptoms of aging . . .without waiting until illness occurs to enjoy the effects of endocrine therapy. In a trial with healthy men (65 to 80 years old), coadministration of low-dose growth hormone and testosterone has shown to produce “beneficial changes,” more often than with either hormone alone. A landmark article reveals even conservative colleagues are focusing on the endocrine system of healthy patients to produce a healthier, higher quality of life.

Review current research and medical articles on energy, productivity and well-being as well as the effects of hormonal modulation, nutrition and lifestyle choices on the matter.


Hormones and Sexuality During Transition to Menopause.pdf

This study confirms the observation that sexual dysfunction increases over the menopausal transition. Several factors associated with sexual dysfunction include low DHEAS, absence of a sexual partner, anxiety, and children under the age of 18 living at home.
Gracia, C.R., Freeman, E.W., Sammel, M.D., Lin, H. & Mogul, M. (2007). Hormones and sexuality during transition to menopause [Electronic version]. Obstetrics and Gynecology, 109(4), 831-840. Retrieved May 31, 2007.

Fountain of Youth Overflows with Hormones.pdf

According to this article, as baby boomers age, the fight against aging is being combated by increased exercise, better eating habits and the use of testosterone and other hormone replenishments.
Stetz, M. (2007, March 5). Fountain of youth overflows with hormones [Electronic version]. The San Diego Union-Tribune. Retrieved May 2, 2007.

Male Menopause.pdf

According to this article, women may not be the only ones who suffer the effects of changing hormones. Some doctors are noticing that their male patients are reporting some of the same symptoms that women experience in menopause.
(2006, April 5). Male menopause [Electronic version]. Cleveland Clinic Website. Retrieved May 2, 2007.

Fountain of Youth? Injections of Human Growth Hormone Are Being Used to Ward Off the Effects of Aging.pdf

This article, which quotes Dr. Alan Mintz, describes the increased use of human growth hormone by aging but relatively healthy people who hope to improve the quality, and perhaps the length, of their lives. It includes discussion for and against the use of growth hormone.
Kohn, D. (2006, April 7). Fountain of youth? Injections of human growth hormone are being used to ward off the effects of aging [Electronic version]. The Baltimore Sun. (PDF).

Daily Activity Energy Expenditure and Mortality Among Older Adults.pdf

In this study, objectively measured free-living activity energy expenditure was strongly associated with lower risk of mortality in healthy older adults. Simply expending energy through any activity may influence survival in older adults.
Manini, T.M., Everhart, J.E., Patel, K.V., Schoeller, D.A., Colbert, L.H., Visser, M., et al. (2006). Daily activity energy expenditure and mortality among older adults [Electronic version]. The Journal of the American Medical Association, 296(2), 171-179. Retrieved May 17, 2007.

Strength, But Not Muscle Mass, Is Associated With Mortality in the Health, Aging and Body Composition Study Cohort.pdf

This study concluded that low muscle mass did not explain the strong association of strength with mortality, demonstrating that muscle strength as a marker of muscle quality is more important than quantity in estimating mortality risk. Grip strength provided risk estimates similar to those of quadriceps strength.
Newman, A.B., Kupelian, V., Visser, M., Simonsick, E.M., Goodpaster, B.H., Kritchevsky, S.B., et al. (2006). Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort [Electronic version]. The Journals of Gerentology,
Series A, Biological Sciences and Medical Sciences, 61(1), 72-77. Retrieved May 14, 2007.

Influences of Calorie Restriction and Age on Energy Expenditure in the Rhesus Monkey.pdf

To assess longitudinal effects of CR on EE in rhesus monkeys (Macaca mulatta), data from 41 males (M) and 26 females (F) subjected to 9 or 15 yr of CR were studied. EE and body composition of monkeys 11-28 yr of age were measured using indirect calorimetry and dual X-ray absorptiometry. Total EE (24-h EE) was divided into daytime (day EE), nighttime (night EE), and daytime minus nighttime (D - N EE).
Raman, A., Ramsey, J.J., Kemnitz, J.W., Baum, S.T., Newton, W., Colman, R.J., et al. (2006). Influences of calorie restriction and age on energy expenditure in the rhesus monkey [Electronic version]. American Journal of Physiology, 292(1), E101-106. Retrieved May 17, 2007.

Male Menopause Out of the Closet.pdf

According to this article, as men age, their testosterone levels gradually decline and some men go through what is now called male menopause. But many never get diagnosed or treated because until now male menopause has been in the closet.
Schieszer, J. (2006, October 1). Male menopause out of the closet [Electronic version]. MSNBC.com Website. Retrieved May 2, 2007.

Endogenous Hormones, Muscle Strength, and Risk of Fall-Related Fractures in Older Women.pdf

This study showed that in 75-year-old women higher serum estradiol concentration and greater muscle strength were independently associated with a low incidence of fall-related limb fractures even after adjustment for bone density. Our results suggest that hormonal status and muscle strength have their own separate mechanisms protecting from fall-related fractures. This finding is of importance in developing preventive strategies, but calls for further study.
Sipila, S., Heikkinen, E., Cheng, S., Suominen, H., Saari, P., Kovanen, V., et al. (2006). Endogenous hormones, muscle strength, and risk of fall-related fractures in older women [Electronic version]. The Journals of Gerentology, Series A, Biological Sciences and Medical Sciences, 61(1), 92-96. Retrieved May 14, 2007.

Total Energy Expenditure in the Yakut (Sakha) of Siberia as Measured by the Doubly Labeled Water Method.pdf

This study concluded that activity levels in the Yakut were lower than those in other subsistence groups, especially the women, and were not significantly different from those in persons in industrialized nations. Persons who participated in more subsistence activities and consumed fewer market foods had significantly higher activity levels.
Snodgrass, J.J., Leonard, W.R., Tarskaia, L.A. & Schoeller, D.A. (2006). Total energy expenditure in the Yakut (Sakha) of Siberia as measured by the doubly labeled water method [Electronic version]. The American Journal of Clinical Nutrition, 84(4), 798-806. Retrieved May 17, 2007.

A Drug’s Promise (or not) of Youth.pdf

The author of this article says that growth hormone is the anti-aging industry’s most potent and controversial weapon. Some say it works wonders. Some say it could shorten your life.
Alexander, B. (2006, July 9). A drug’s promise (or not) of youth [Electronic version]. LATimes.com. Retrieved November 15, 2006.

Does Growth Hormone Cause Cancer?.pdf

This study concluded that even if GH/IGF-1 therapy does result in a small increase in cancer risk compared to untreated patients with GH deficiency, it is likely that the eventual risk will be the same as the general population. Such a restoration to normality will need to be balanced against the known morbidity of untreated GH deficiency.
Jenkins, P.J., Mukherjee, A. & Shalet, S.M. (2006). Does growth hormone cause cancer? [Electronic version]. Clinical Endocrinology (Oxford), 64(2), 115-121. Retrieved November 14, 2006.

Lowering Dietary Glycemic Load for Weight Control and Cardiovascular Health: A Matter of Quality.pdf

This study concludes that although significant differences in neurohormonal responses to different types of carbohydrates have long been recognized, until recently this knowledge has not been comprehensively and systematically applied to the study of diet and CVD in populations or to the development of food-composition tables in guiding dietary practice.
Liu. S. (2006). Lowering dietary glycemic load for weight control and cardiovascular health: a matter of quality [Electronic version]. Archives of Internal Medicine, 166(14), 1438-1439. Retrieved November 14, 2006.

Prevalence of Hypogonadism in Males Aged at Least 45 Years: The HIM study.pdf

According to this study, based on TT concentration, the prevalence of hypogonadism in men reporting to primary care offices was estimated to be 38.7%. The medical conditions that occurred significantly more frequently among hypogonadal men than eugonadal men included increased BMI, hypertension, hyperlipidaemia, diabetes, and asthma or COPD. As men age, they are susceptible to conditions that share many of the same symptoms similar to hypogonadism. The presence of these conditions may, in effect, mask underlying hypogonadism and negatively impact quality of life.
Mulligan, T., Frick, M.F., Zuraw, Q.C., Stemhagen, A. & McWhirter, C. (2006). Prevalence of hypogonadism in males aged at least 45 years: the HIM study [Electronic version]. International Journal of Clinical Practice, 60(7), 762-769. Retrieved November 27, 2006.

DHEA in Elderly Women and DHEA or Testosterone in Elderly Men.pdf

This study concluded that neither DHEA nor low-dose testosterone replacement in elderly people has physiologically relevant beneficial effects on body composition, physical performance, insulin sensitivity, or quality of life.
Nair, K.S., Rizza, R.A., O'Brien, P., Dhatariya, K., Short, K.R., Nehra, A., et al. (2006). DHEA in elderly women and DHEA or testosterone in elderly men [Electronic version]. The New England Journal of Medicine, 355(16), 1647-1659. Retrieved November 27, 2006.

Hormone Profiles After Intramuscular Injection of Testosterone Enanthate in Patients with Hypogonadism.pdf

To examine hormone levels after androgen replacement therapy (ART) in Japanese male patients with hypogonadism, nine Japanese male patients with hypogonadism (serum total testosterone (tT) or free testosterone (fT) levels of < or = 2.7 ng/mL or < or = 10 pg/mL, respectively; average age, 59 years) were enrolled.
Nakazawa, R., Baba, K., Nakano, M., Katabami, T., Saito, N., Takahashi, T., et al. (2006). Hormone profiles after intramuscular injection of testosterone enanthate in patients with hypogonadism  [Electronic version]. Endocrine Journal, 53(3), 305-310. Epub May 19, 2006. Retrieved November 27, 2006.

Hormones May Hold Clues to Healthy Aging.pdf

Two new studies suggest that specific hormones may play a key role in longevity and healthy aging.  Researchers found one hormone, adiponectin, at higher-than-average concentrations in 100-year-old women, while another study found that stimulating the body's production of growth hormone brought a youthful pep back to people in their 60s to 80s.
Reinberg, S. (2006, June 21). Hormones may hold clues to healthy aging [Electronic version]. HealthDay News. Retrieved July 18, 2006.

Low Serum Testosterone and Mortality in Male Veterans.pdf

This study used a clinical database to identify men older than 40 years with repeated testosterone levels obtained from October 1, 1994 to December 31, 1999, and without diagnosed prostate cancer.  It concluded that low testosterone levels were associated with increased mortality in male veterans. Further prospective studies are needed to examine the association between low testosterone levels and mortality.
Shores, M.M., Matsumoto, A.M., Sloan, K.L. & Kivlahan, D.R. (2006). Low serum testosterone and mortality in male veterans [Electronic version]. Archives of Internal Medicine, 166(15), 1660-1665. Retrieved August 28, 2006.

Management of Andropause: The Male Menopause.pdf

According to this article, andropause is a syndrome of physical, sexual, and psychological symptoms in aging men due to a gradual decline in serum testosterone levels. Its symptoms are more prominent in the presence of concomitant medical disorders. Testosterone replacement therapy relieves these symptoms along with improvement in bone and muscle mass, sexual function, and quality of life.
Tunuguntla, H.S.G.R. (2005, November), Management of andropause: the male menopause [Electronic version]. Clinical Geriatrics, 13(11), 27-34. Retrieved May 2, 2007.

Study Links Fat Distribution and Not Body Weight as an Indicator of Cardiovascular Disease Risk.pdf

GE Healthcare, a unit of General Electric Company (NYSE: GE), announced that the company’s Lunar Prodigy bone density system was used in a groundbreaking study to evaluate body composition and fat distribution in the body as an important indicator of risk of cardiovascular disease.  The study was presented at the 27th Annual Meeting of the American Society for Bone and Mineral Research meeting in Nashville, TN, September 23-27.
(2005, September 23). Study links fat distribution and not body weight as an indicator of cardiovascular disease risk [Electronic version]. (PDF)

Chocolate Does Not Contain Caffeine.pdf

According to this article, there is a persistent urban legend that Chocolate contains caffeine.  It would seem that this rumor is based primarily on a confusion between two similar alkaloids:  Caffeine and Theobromine.  Theobromine is the active ingredient in Chocolate and it occurs only in Cacao.  The two stimulants are related and have similar structures, but are very different chemicals with different properties, effects and origins. There are of course, some Chocolate products that have added Caffeine, but it does not occur naturally in Chocolate.
Chocolate does not contain caffeine [Electronic version]. Xocoatl.org Website. Retrieved October 11, 2005.

Effects of Exercise and Stress Management Training on Markers of Cardiovascular Risk in Patients with Ischemic Heart Disease: A Randomized Controlled Trial.pdf

In this randomized controlled trial, it was concluded that for patients with stable Ischemic Heart Disease (IHD), exercise and stress management training reduced emotional distress and improved markers of cardiovascular risk more than usual medical care alone.
Blumenthal, J.A., Sherwood, A., Babyak, M.A., Watkins, L.L., Waugh, R., Georgiades, A., et al. (2005). Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial [Electronic version]. The Journal of the American Medical Association, 293(13), 1626-1634. Retrieved May 17, 2005.

Experts Consider HT for Younger Women.pdf

Questions still persist after the release of the July 2002 Women’s Health Initiative findings regarding hormone therapy.  Researchers have been looking at the data to see if certain changes in dosage or initiation age could still provide benefits to women.
Elliott, V.S., (2005, February 28). Experts consider HT for younger women [Electronic version]. American Medical News, pp. 19-20.  Retrieved April 28, 2005.

Toward the Development of a Test for Growth Hormone (GH) Abuse: A Study of Extreme Physiological Ranges of GH-Dependent Markers in 813 Elite Athletes in the Postcompetition Setting.pdf

This study was undertaken to determine the physiological range of these GH-dependent variables in elite athletes after a competitive event to determine whether such values differ from resting values in normal and athletic subjects and to establish whether any adjustments to this range are required on the basis of age, gender, demographic characteristics, or the nature of the exercise performed.
Healy, M.L., Dall, R., Gibney, J., Bassett, E., Ehrnborg, C., Pentecost, C., et al. (2005). Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 90(2), 641-649. Epub 2004, November 16. Retrieved November 18, 2005.

Effects of Estrogen with and without Progestin on Urinary Incontinence.pdf

The conclusion of this study was that conjugated equine estrogen alone and CEE + MPA increased the risk of UI among continent women and worsened the characteristics of UI among symptomatic women after 1 year. Conjugated equine estrogen with or without progestin should not be prescribed for the prevention
Hendrix, S.L., Cochrane, B.B., Nygaard, I.E., Handa, V.L., Barnabei, V.M., Iglesia, C., et al. (2005). Effects of estrogen with and without progestin on urinary incontinence [Electronic version]. The Journal of the American Medical Association, 293(8), 935-948. Retrieved November 18, 2005.

Male Hormones Could Help Slow Aging in Men, WU Doctor Says.pdf

According to this article, the natural medical response to decreasing testosterone in men is to want to replenish low hormone levels. Yet no large-scale study has done for men what the massive Women's Health Initiative did for women: Investigate the effects of replacing important sex hormones in the aging. But as demographic shifts bring an increasingly older population, male hormone replacement therapy, or HRT, is becoming a priority.
Kean, S. (2005, August 2). Male hormones could help slow aging in men, WU doctor says [Electronic version]. St. Louis Post-Dispatch. Retrieved October 20, 2005.

Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression.pdf

This study found DHEA to be an effective treatment for midlife-onset major and minor depression.
Schmidt, P.J., Daly, R.C., Bloch, M., Smith, M.J., Danaceau, M.A., St. Clair, L.S., et al. (2005). Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression [Electronic version]. Archives of General Psychiatry, 62(2), 154-162. Retrieved November 18, 2005.

Hormone Replacement, the Male Version.pdf

According to this article, a growing number of men in the United States are now taking testosterone to reverse the gradual, age-related decline of the hormone, or so-called andropause. By some estimates, the number of testosterone prescriptions in the United States has tripled in recent years, and total sales now come to about $400 million a year. That’s not much compared with the $12.5 billion spent on cholesterol-lowering statins, but the upward trend is still impressive.
(2004, May). Hormone replacement, the male version [Electronic version]. Harvard Health Letter. Retrieved May 2, 2007.

One Year Follow-up Study of the Association Between Chemical Castration, Sex Hormones, Beta-Amyloid, Memory and Depression in Men.pdf

The results of this naturalistic study indicate that chemical castration is associated with a significant rise in the plasma levels of Abeta and, clinically, with increased depression and anxiety scores. The discontinuation of treatment is associated with better cognitive performance, most noticeably of verbal memory. The performance of subjects on the WL test was negatively correlated with plasma levels of Abeta, but the clinical significance of this finding remains to be determined.
 Almeida, O.P., Waterreus, A., Spry, N., Flicker, L. & Martins, R.N. (2004). One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men [Electronic version]. Psychoneuroendocrinology, 29(8), 1071-1081. Retrieved November 18, 2005.

Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone.pdf

The results of this study demonstrate that T therapy in older men with low serum T increases vertebral and hip BMD over 36 months, both when administered alone and when combined with F. This finding suggests that dihydrotestosterone is not essential for the beneficial effects of T on BMD in men. In addition, the concomitant administration of F with T appears to attenuate the impact of T therapy on prostate size and PSA and might reduce the chance of benign prostatic hypertrophy or other prostate-related complications in older men on T therapy. These findings have important implications for the prevention and treatment of osteoporosis in older men with low T levels.
Amory, J.K., Watts, N.B., Easley, K.A., Sutton, P.R., Anawalt, B.D., Matsumoto, A.M., et al. (2004). Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 89(2), 503-510. Retrieved November 21, 2005.

Safety and Adverse Effects of Androgens: How to Counsel Patients.pdf

In short-term clinical trials of androgen replacement in women, several benefits have been shown, including improved libido, bone mineral density and body composition.  While androgen therapy for women is relatively new, it is receiving more attention.
Basaria, S. & Dobs, A.S. (2004). Safety and adverse effects of androgens: how to counsel patients [Electronic version]. Mayo Clinic Proceedings, 79(4 Suppl.), S25-32. Retrieved May 18, 2005.

Formulations and Use of Androgens in Women.pdf

The use of androgen therapy for postmenopausal women is discussed in this article.  It suggests that the goal of androgen treatment should be to achieve normal premenopausal levels of testosterone, thus limiting adverse effects and adverse experiences. 
Chu, M.C. & Lobo, R.A. (2004). Formulations and use of androgens in women. [Electronic version]. Mayo Clinic Proceedings, 79(4 Suppl.), S3-7. Retrieved May 18, 2005.

Insulin-Like Growth Factor-1 as a Vascular Protective Factor.pdf

According to this study, until recently, IGF-1 was considered a mediator of vascular disease. Increasing evidence indicates, instead, that IGF-1 protects against endothelial dysfunction, atherosclerotic plaque development, the metabolic syndrome, clinical instability, and ischemic myocardial damage.
Conti, E., Carrozza, C., Capoluongo, E., Volpe, M., Crea, F., Zuppi, C., et al. (2004). Insulin-like growth factor-1 as a vascular protective factor [Electronic version]. Circulation, 110(15), 2260-2265. Retrieved May 18, 2005.

Potential Anabolic Effects of Androgens on Bone.pdf

With the decrease of estrogen at menopause, the need for androgens increases in post-menopausal women.  Androgens also appear to be important for the bone health of women who are pre-menopausal.
Kearns, A.E. & Khosla, S. (2004). Potential anabolic effects of androgens on bone [Electronic version]. Mayo Clinic Proceedings, 79(4 Suppl.), S14-18. Retrieved May 18, 2005.

Review of the Book The Sexy Years: Discover the Hormone Connection: The Secret to Fabulous Sex, Great Health, and Vitality, for Women and Men.pdf

Review by Amazon.com of Suzanne Somers’ book The Sexy Years: Discover the Hormone Connection: The Secret to Fabulous Sex, Great Health, and Vitality, for Women and Men.
Lightner, J. (2004). [Review of the book The sexy years: Discover the hormone connection: the secret to fabulous sex, great health, and vitality, for women and men]. Retrieved September 10, 2004.

Hot Flashes and Androgens: A Biological Rationale for Clinical Practice.pdf

This article discusses the important role androgens play in the treatment of hot flashes.  It also emphasizes the need to individualize treatment for menopausal women.
Notelovitz, M. (2004). Hot flashes and androgens: a biological rationale for clinical practice [Electronic version]. Mayo Clinic Proceedings, 79(4 Suppl.), S8-13. Retrieved May 18, 2005.

Low Androgenization Index in Elderly Women and Elderly Men with Alzheimer's Disease.pdf

The authors of this study investigated whether testosterone levels and testosterone availability differ between older lean subjects with and without Alzheimer's disease (AD). Sex hormone binding globulin (SHBG) and estradiol levels were higher, whereas the free androgenization index (FAI) was lower, in lean subjects with AD than in lean subjects without AD. Factors involved in the increase of SHBG secretion could have an important role in the lower testosterone availability of subjects with AD.
Paoletti, A.M., Congia, S., Lello, S., Tedde, D., Orru, M., et al. (2004). Low androgenization index in elderly women and elderly men with Alzheimer's disease [Electronic version]. Neurology. 62(2), 301-303. Retrieved September 27, 2005.

Retrospective Analysis of the Impact of a Low Glycaemic Index Diet on Hospital Stay Following Coronary Artery Bypass Grafting: A Hypothesis.pdf

This study provides further support that carbohydrate and fat metabolism influence cardiac outcome and provides new evidence that dietary modification prior to coronary artery bypass surgery can shorten the hospital stay.
Patel, V.C., Aldridge, R.D., Leeds, A., Dornhorst, A. & Frost G.S. (2004). Retrospective analysis of the impact of a low glycaemic index diet on hospital stay following coronary artery bypass grafting: a hypothesis [Electronic version]. Journal of Human Nutrition & Dietetics, 17(3), 241-247. Retrieved May 17, 2005.

Diet Composition and the Risk of Type 2 Diabetes: Epidemiological and Clinical Evidence.pdf

This article concludes that new emphasis on prevention by multiple lifestyle modifications, including moderate changes in the composition of the habitual diet, might limit the dramatic increase in incidence of type 2 diabetes envisaged worldwide.
Parillo, M. & Riccardi, G. (2004). Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidence [Electronic version]. The British Journal of Nutrition, 92(1), 7-19. Retrieved September 27, 2005.

Risks of Testosterone-Replacement Therapy and Recommendations for Monitoring.pdf

According to this study, hypogonadism affects an estimated 2 million to 4 million men in the United States; its prevalence increases with age. However, it has been estimated that only 5 percent of affected men currently receive treatment. Recent interest in testosterone therapy has been fueled not only by increased medical awareness of the effects of hypogonadism, but also by media attention regarding hormone-replacement therapy in both men and women, the marketing of new topical testosterone formulations, and the desire of "baby boomers" to maintain vigor and health into their more mature years.
Rhoden, E.L. & Morgentaler, A. (2004). Risks of testosterone-replacement therapy and recommendations for monitoring [Electronic version]. The New England Journal of Medicine, 350(5), 482-492. Retrieved September 27, 2005.

The Paradox of the Insulin/IGF-1 Signaling Pathway in Longevity.pdf

This review focuses on the downstream cascade of events in the insulin and IGF-1 signaling to identify specific pathways that are relevant to human longevity.

Rincon, M., Muzumdar, R., Atzmon, G. & Barzilai, N. (2004). The paradox of the insulin/IGF-1 signaling pathway in longevity [Electronic version].  Mechanisms of Ageing & Development, 125(6), 397-403. Retrieved September 19, 2005.

Long-Term Improvement of Quality of Life During Growth Hormone (GH) Replacement Therapy in Adults with GH Deficiency, as Measured by Questions on Life Satisfaction-Hypopituitarism (QLS-H).pdf

This study demonstrates that 1) improvements in QoL, as measured by the QLS-H, are maintained during long-term GH replacement therapy of adults with GHD, and 2) the QLS-H is a useful tool for evaluating QoL in hypopituitary patients treated in clinical practice. The authors suggest that evaluation of QoL should be a part of the routine clinical management of adult GH-deficient patients, complementing the measurement of surrogate biological markers or other clinical end points.
Rosilio, M., Blum, W.F., Edwards, D.J., Shavrikova, E.P., Valle, D., Lamberts, S.W., et al. (2004). Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H) [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 89(4), 1684-1693. Retrieved November 21, 2005.

Testosterone Treatment Improves Body Composition and Sexual Function in Men with COPD, in a 6-Month Randomized Controlled Trial.pdf

This article concludes that administration of a low-dose testosterone to men with COPD for 26 weeks was associated with improvement of body composition, better erectile function and sexual quality of life. Furthermore, there were no clinical or biochemical side effects.
Svartberg, J., Aasebo, U., Hjalmarsen, A., Sundsfjord, J. & Jorde, R. (2004). Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial [Electronic version]. Respiratory Medicine, 98(9), pp. 906 - 913. Retrieved September 10, 2004.

Nuts, Omega-3s and Food Labels.pdf

According to this letter, arguably, the most successful secondary prevention trial for heart disease was the Lyon Diet Heart Study, in which the only intervention was a daily dose of about 2 tablespoons (about 30 mL) of unhydrogenated canola oil in the form of a margarine. Omega-3 fatty acids are vitally important, and our new food labels should indeed help us to make informed choices.
Vos, E. (2004). Nuts, omega-3s and food labels [Electronic version]. Canadian Medical Association Journal, 171(8), 829. Retrieved November 1, 2005.

Dehydroepiandrosterone Increases Endothelial Cell Proliferation in Vitro and Improves Endothelial Function in Vivo by Mechanisms Independent of Androgen and Estrogen Receptors.pdf

The subject of this study was Dehydroepiandrosterone (DHEA).   It was examined to determine its effects on the proliferation of cultured endothelial cells, compare its effects with those of estradiol and testosterone, and examine its effects on subcellular messengers.
Williams, M.R., Dawood, T., Ling, S., Dai, A., Lew, R., Myles, K., Funder, J.W., Sudhir, K. & Komesaroff, P.A. (2004). Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors [Electronic version].  The Journal of Clinical Endocrinology and Metabolism, 89(9), 4708-4715. Retrieved May 18, 2005.

Reduced Longevity in Untreated Patients with Isolated Growth Hormone Deficiency.pdf

The aim of this study was to analyze the impact of untreated GHD on life span. Hereditary dwarfism was recognized in 11 subjects.
Besson, A., Salemi, S., Gallati, S., Jenal, A., Horn, R., et al. (2003). Reduced longevity in untreated patients with isolated growth hormone deficiency [Electronic version]. The Journal of Clinical Endocrinology & Metabolism, 88(8), 3664-3667. Retrieved September 26, 2005.

Dehydroepiandrosterone Replacement in Healthy Men with Age-Related Decline of DHEA-S: Effects on Fat Distribution, Insulin Sensitivity and Lipid Metabolism.pdf

The results of this study did not reveal any significant changes in study parameters, apart from a statistically significant increase in DHEA-S levels after therapy with active substance.
Jedrzejuk, D., Medras, M., Milewicz, A. & Demissie, M. (2003). Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism [Electronic version]. The Aging Male, 6(3), 151-156. Retrieved December 7, 2005.

A Diet Rich in Coconut Oil Reduces Diurnal Postprandial Variations in Circulating Tissue Plasminogen Activator Antigen and Fasting Lipoprotein (a) Compared with a Diet Rich in Unsaturated Fat in Women.pdf

The results of this study indicated that a coconut oil-based diet (HSAFA-diet) lowers postprandial t-PA antigen concentration, and this may favorably affect the fibrinolytic system and the Lp(a) concentration compared with the HUFA-diet. The proportions of dietary saturated fatty acids more than the percentage of saturated fat energy seem to have a beneficial influence on Lp(a) levels.
Muller, H., Lindman, A.S., Blomfeldt, A., Seljeflot, I. & Pedersen, J.I. (2003). A diet rich in coconut oil reduces diurnal postprandial variations in circulating tissue plasminogen activator antigen and fasting lipoprotein (a) compared with a diet rich in unsaturated fat in women [Electronic version]. The Journal of Nutrition, 133(11), 3422-3427. Retrieved November 1, 2005.

Endogenous Sex Hormones and Cardiovascular Disease in Men.pdf

The purpose of this article is to summarize the evidence currently available on the association between endogenous sex hormones and cardiovascular disease in males. Published studies dealing with the relationship between circulating levels of sex hormones and cardiovascular disease in males were reviewed. The studies reviewed in this article suggest that circulating endogenous sex hormones and estrogens have a neutral or beneficial effect on cardiovascular disease in men.
Muller, M. van der Schouw, Y.T.,Thijssen, J.H. & Grobbee, D.E. (2003). Endogenous sex hormones and cardiovascular disease in men [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 88(11), 5076-5086. Retrieved September 27, 2005.

Does Testosterone Boost an Actor's Oscar Odds?.pdf

Testosterone surges may be one of the factors that separate Oscar-winners like Jack Nicholson and Al Pacino from aspiring actors whose careers never get off the ground, new study findings suggest.
Stenson, J. (2003, March 21). Does testosterone boost an actor's Oscar odds? [Electronic version]. Reuters Health. Retrieved October 31, 2005.

Quality of Life of Growth Hormone (GH) Deficient Young Adults During Discontinuation and Restart of GH Therapy.pdf

It is concluded that one year discontinuation of GH treatment leads to a decrease in QoL within 6 months which effect is counteracted within 6 months after restart of GH treatment.
Stouthart, P.J., Deijen, J.B., Roffel, M. & Delemarre-van de Waal, H.A. (2003). Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy [Electronic version]. Psychoneuroendocrinology, 28(5), 612-626. Retrieved December 7, 2005.

Dehydroepiandrosterone Augmentation in the Management of Negative, Depressive, and Anxiety Symptoms in Schizophrenia.pdf

The preliminary observations report for the first time in double-blind fashion the efficacy of DHEA augmentation in the management of negative, depressive, and anxiety symptoms of schizophrenia. The findings from this study raise important issues regarding the role of neurosteroids in general, and DHEA in particular, in the ongoing symptomatology and pharmacotherapy of schizophrenia.
Strous, R.D., Maayan, R., Lapidus, R., Stryjer, R., Lustig, M., Kotler, M., et al. (2003). Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia [Electronic version]. Archives of General Psychiatry, 60(2), 133-141. Retrieved December 7, 2005.

Can Growth Hormone Prevent Aging?.pdf

This article cites the article by Rudman et al. that appeared in the Journal in 1990 that reported the effect on body composition of administering human growth hormone for six months to 12 older men. This article incited a proliferation of "antiaging" clinics and lay publications, such as "Grow Young with HGH," extolling the benefits of growth hormone in reversing or preventing aging.
Vance, M.L. (2003). Can growth hormone prevent aging? [Electronic version]. The New England Journal of Medicine, 348(9), 779-780. Retrieved October 31, 2005.

Recombinant Human Growth Hormone Treatment in Elderly Patients Undergoing Elective Total Hip Replacement.pdf

This study concluded that in elderly patients undergoing total hip replacement, preoperative GH treatment results in improvements in lean body mass and skeletal muscle mass that are sufficient to offset postoperative losses.  The treatment may also preserve or improve muscle strength and postoperative walking ability.
Weissberger, A.J., Anastasiadis, A.D., Sturgess, I., Martin, F.C., Smith, M.A. & Sonksen, P.H. (2003). Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement [Electronic version]. Clinical Endocrinology (Oxford), 58(1), 99-107. Retrieved May 17, 2005.

Single and Combined Effects of Growth Hormone and Testosterone Administration on Measures of Body Composition, Physical Performance, Mood, Sexual Function, Bone Turnover, and Muscle Gene Expression in Healthy Older Men.pdf

This study examined the effects of GH and/or testosterone (T) administration on body composition, performance, mood, sexual function, bone turnover, and muscle-gene expression in healthy older men.  It concluded that 1 month of GH and/or T administration improves certain measures of balance and physical performance in older men and increases muscle IGF-I gene expression.
Brill, K.T., Weltman, A.L., Gentili, A., Patrie, J.T., Fryburg, D.A., Hanks, J.B., et al. (2002). Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 87(12), 5649-5657. Retrieved January 4, 2006.

Severely Burned Patients After Surgery: Recombinant Human Growth Hormone Therapy its Metabolic Effects.pdf

This study concludes that recombinant human growth hormone (rhGH) has a beneficial effect on metabolism in patients who are severely burned.  Hyperglycemia, however, is apt to occur and water, Na(+), Cl(-) retention are suggested.  Fifty patients were studied.
Chai, J., Hao, D., Wu, Y., Shen, C., Guo, Z. & Sheng, Z. (2002). [Severely burned patients after surgery: recombinant human growth hormone therapy its metabolic effects] [Article in Chinese] [Electronic version]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery], 40(2), 107-111. Retrieved May 18, 2005.

The Cardiovascular Risk of Adult GH Deficiency (GHD) Improved After GH Replacement and Worsened in Untreated GHD: A 12-Month Prospective Study.pdf

This study concluded that 12 months of GH replacement normalized IGF-I and improved lipid profile and cardiac performance in adult GHD patients. A similar period of GH deprivation induced a further impairment of lipid profile and cardiac performance. This finding strongly supports the need of GH replacement in adult GHD patients.
Colao, A., di Somma, C., Pivonello, R., Cuocolo, A., Spinelli, L., et al. (2002).  The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study [Electronic version]. The Journal of Clinical Endocrinology & Metabolism, 87(3), 1088-1093. Retrieved September 26, 2005.

Shouldn't Adults with Growth Hormone Deficiency Be Offered Growth Hormone Replacement Therapy?.pdf

This analysis should encourage reluctant practitioners to at least consider growth hormone replacement therapy for patients with definite growth hormone deficiency--that is, patients with symptomatic panhypopituitarism.
Cook, D.M. (2002). Shouldn't adults with growth hormone deficiency be offered growth hormone replacement therapy? [Electronic version]. Annals of Internal Medicine, 137(3), 197-201. Retrieved September 26, 2005.

The Effects of Tibolone on Mood and Libido.pdf

According to this paper, published studies indicate beneficial effects of tibolone on both libido and mood, which otherwise significantly compromise physical, psychological, and social well-being. Hence, tibolone provides another option for menopausal women experiencing loss of libido as part of their symptomatology or who have persistent low libido despite adequate estrogen/progestin replacement therapy.
Davis, S.R. (2002). The effects of tibolone on mood and libido [Electronic version]. Menopause, 9(3), 162-170. Retrieved October 3, 2005.

GH-Deficient Survivors of Childhood Cancer: GH Replacement During Adult Life.pdf

This article proposes that, as in patients with hypopituitarism caused by pituitary disease, the main indication for GH replacement in GH-deficient survivors of childhood cancer should be severe impairment of quality of life.
Murray, R.D., Darzy, K.H., Gleeson, H.K. & Shalet, S.M. (2002). GH-deficient survivors of childhood cancer: GH replacement during adult life [Electronic version]. The Journal of Clinical Endocrinology & Metabolism, 87(1), 129-135. Retrieved September 26, 2005.

Differential Effects of Glucocorticoids and Gonadal Steroids on Glutathione Levels in Neuronal and Glial Cell Systems.pdf

This study demonstrates differential effects of steroids on GSH levels in different cellular CNS models, showing an important influence of steroids and especially E(2) on antioxidative cellular functions in neuronal and glial cells.
Schmidt, A.J., Krieg, J.C. & Vedder, H. (2002). Differential effects of glucocorticoids and gonadal steroids on glutathione levels in neuronal and glial cell systems [Electronic version]. Journal of Neuroscience Research, 67(4), 544-550. Retrieved October 3, 2005.

Exercise Type and Intensity in Relation to Coronary Heart Disease in Men.pdf

This study concluded that total physical activity, running, weight training, and walking were each associated with reduced CHD risk. Average exercise intensity was associated with reduced risk independent of the number of MET-hours spent in physical activity.
Tanasescu, M., Leitzmann, M.F., Rimm, E.B., Willett, W.C., Stampfer, M.J. & Hu, F.B. (2002). Exercise type and intensity in relation to coronary heart disease in men [Electronic version]. The Journal of the American Medical Association, 288(16), 1994-2000. Retrieved September 27, 2005.

Body Composition and Quality of Life in Adults with Growth Hormone Deficiency; Effects of Low-Dose Growth Hormone Replacement.pdf

This study discusses how low-dose GHR improves body composition and QoL as early as 1 month after commencement and the beneficial effects continue at 3 months. Most importantly, these changes occur in the absence of side-effects.
Ahmad, A.M., Hopkins, M.T., Thomas, J., Ibrahim, H., Fraser, W.D., et al. (2001). Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement [Electronic version]. Clinical Endocrinology (Oxford), 54(6), 709-717. Retrieved September 14, 2005.

Association of IGF-I Levels with Muscle Strength and Mobility in Older Women.pdf

This article summarizes that in a study population including frail and healthy older women, low IGF-I levels were associated with poor knee extensor muscle strength, slow walking speed, and self-reported difficulty with mobility tasks. These findings suggest a role for IGF-I in disability as well as a potential target population for interventions to raise IGF-I levels.
Cappola, A.R., Bandeen-Roche, K., Wand, G.S., Volpato, S. & Fried, L.P. (2001). Association of IGF-I levels with muscle strength and mobility in older women [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 86(9), 4139-4146. Retrieved September 28, 2005.

Improved Cardiovascular Risk Factors and Cardiac Performance After 12 Months of Growth Hormone (GH) Replacement in Young Adult Patients with GH Deficiency.pdf

This article concludes that GH replacement for 12 months significantly improved lipid profile, decreased fibrinogen levels, and increased LVMi and LVEF in young adults with co- or ao-GHD. However, lipid profile, fibrinogen levels, and systolic function remained abnormal compared with those in age- and sex-matched controls, suggesting that a longer period of GH replacement is necessary to normalize cardiovascular parameters and reverse the cardiovascular risk of these patients.
Colao, A., di Somma, C., Cuocolo, A., Spinelli, L., Tedesco, N., et al. (2001).  Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency [Electronic version].  The Journal of Clinical Endocrinology & Metabolism, 86(5), 1874-1881. Retrieved September 26, 2005.

What are "Normal" Testosterone Levels for Women?.pdf

In this Letter to the Editor, the authors conclude that the role of androgens in women is becoming increasingly more recognized and established. Certainly, the use of androgens, particularly testosterone, has been shown to influence life aspects, such as mood, women’s general well being and restoration of sexual desire. However, there is limited data establishing normal androgen values for women of differing ages, to enable us to define those with "androgen deficiency." They say it is, therefore, necessary to highlight the incongruencies and short-comings of the paper by Laughlin et al. (Laughlin G, Barrett-Connor E, Kritz-Silverstein D, Von Muhlen D. 2000 Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernado Study. J Clin Endocrinol Metab. 85:645–651), and the need for larger prospective studies to establish the variations in testosterone levels in women with age.
Davis, S. & Tran, J. (2001). What are "normal" testosterone levels for women? [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 86(4), 1842-1844. Retrieved October 3, 2005.

Personal Business; Trying to Roll Back the Biological Clock, for a Price.pdf

This article, written soon after September 11th, says that Americans have been re-evaluating their priorities since the attacks, and for some people that means paying closer attention to their health. There has even been a rise in interest in so-called anti-aging clinics.  It discusses several clinics, including Cenegenics.
Siwolop, S. (2001, October 21). Personal business; trying to roll back the biological clock, for a price [Electronic version]. The New York Times. Retrieved October 31, 2005.

Androgen Replacement Therapy in the Aging Male--A Critical Evaluation.pdf

This article concludes that aging is unavoidable and physiologic, but the large interindividual disparity in the pace of development and progression of signs and symptoms of aging, suggests that the development of this symptomatology can be delayed and that a high quality of life can be maintained until a very advanced age, in other words that it is possible to add life to years. Being aware of these possibilities, more and more elderly men (and women) will seek medical help to achieve these goals.
Vermeulenn, A. (2001). Androgen replacement therapy in the aging male--a critical evaluation [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 86(6), 2380-2390. Retrieved October 3, 2005.

Business Unusual:  Cenegenics CEO Sets His Sights on Staying Young; Sports Fanatic Takes Swing at Board Games; U.S. Military Gets Technology Upgrade.pdf

This transcript from Business Unusual includes responses given by Dr. Alan Mintz as well as two Cenegenics patients.
(2000, October 29). Business Unusual:  Cenegenics CEO sets his sights on staying young; sports fanatic takes swing at board games; U.S. military gets technology upgrade [Electronic version]. CNN.com Website. Retrieved October 31, 2005.

Transdermal Testosterone Gel Improves Sexual Function, Mood, Muscle Strength, and Body Composition Parameters in Hypogonadal Men. Testosterone Gel Study Group.pdf

This study concluded that T gel replacement improved sexual function and mood, increased lean mass and muscle strength (principally in the legs), and decreased fat mass in hypogonadal men with less skin irritation and discontinuation compared with the recommended dose of the permeation-enhanced T patch.
Wang, C., Swedloff, R.S., Iranmanesh, A., Dobs, A., Snyder, P.J., Cunningham, G., et al. (2000). Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone gel study group [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 85(8), 2839-2853. Retrieved July 19, 2003.

Growth Hormone Replacement in Adults with Growth Hormone Deficiency: Assessment of Current Knowledge.pdf

This article states that recent availability of recombinant human growth hormone (GH) has led to intense investigation of the consequences of adult GH deficiency (GHD) and the effects of GH replacement. These studies have led to the identification of a characteristic syndrome of GHD consisting of decreased mood and well-being, with alterations in body composition and substrate metabolism.
Carroll, P.V., Christ, E.R. & Sonksen, P.H. (2000). Growth hormone replacement in adults with growth hormone deficiency: assessment of current knowledge [Electronic version]. Trends in Endocrinology and Metabolism, 11(6), 231-238. Retrieved January 18, 2006.

Testosterone Replacement Therapy for Anxiety.pdf

In this Letter to the Editor, the authors report the case of a patient with previously undiagnosed hypogonadism whose anxiety symptoms improved after he received testosterone injections.
Cooper, M.A. & Ritchie, E.C. (2000). Testosterone replacement therapy for anxiety [Electronic version]. The American Journal of Psychiatry, 157(11), 1884. Retrieved October 3, 2005.

Testosterone Therapy in Men: An Update.pdf

This article discusses that because testosterone levels decline with age, and aging is accompanied by body changes including loss of muscle and increases in fat, there is great interest in the potential benefits of testosterone administration in elderly men.
Katznelson, L. (2000, Winter). Testosterone therapy in men: an update [Electronic version]. MGH Neuroendocrine Clinical Center Newsletter Bulletin, 6(2). Retrieved September 14, 2005.

A Prospective Study of Dietary Glycemic Load, Carbohydrate Intake, and Risk of Coronary Heart Disease in US Women.pdf

These epidemiologic data suggest that a high dietary glycemic load from refined carbohydrates increases the risk of CHD, independent of known coronary disease risk factors.
Liu, S., Willett, W.C., Stampfer, M.J., Hu, F.B., Franz, M., et al. (2000). A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women [Electronic version]. The American Journal of Clinical Nutrition, 71(6), 1455-1461. Retrieved September 14, 2005.

Testosterone Replacement and the Physiologic Aspects of Aging in Men.pdf

The focus of the clinical investigations described here is to determine whether testosterone deficiency is a physiologic cause of the aging process and whether testosterone replacement might prevent or ameliorate a decline in quality of life associated with age-related decline in physical and psychological functioning.
Morley, J.E. (2000). Testosterone replacement and the physiologic aspects of aging in men [Electronic version]. Mayo Clinic Proceedings, 75 Suppl., S83-7. 
Retrieved October 3, 2005.

Experience with Testosterone Replacement in the Elderly.pdf

According to this discussion, to date, most of the studies of androgen replacement have been done with healthy older men (age > or = 55 years), and almost no data are available for frail elderly individuals. Treatment effects that make a relatively small difference in younger, more robust individuals may have a greater effect on the elderly, whose improvement in functioning and level of activity may be more dramatic.
Tenover, J.L. (2000). Experience with testosterone replacement in the elderly [Electronic version]. Mayo Clinic Proceedings, 75 Suppl., S77-81, discussion S82. Retrieved January 25, 2006.

Biotransformation of Oral Dehydroepiandrosterone in Elderly Men: Significant Increase in Circulating Estrogens.pdf

This study concludes that 50 mg DHEA seems to be a suitable substitution dose in elderly men, as it leads to serum DHEAS concentrations usually measured in young healthy adults. The DHEA-induced increase in circulating estrogens may contribute to beneficial effects of DHEA in men.
Arlt, W., Haas, J., Callies, F., Reincke, M., Hubler, D., Oettel, M., et al. (1999). Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 84(6), 2170-2176. Retrieved January 19, 2006.

Risks Versus Benefits of Testosterone Therapy in Elderly Men.pdf

This review discusses the pros and cons of testosterone replacement in hypogonadal elderly men and attempts to answer some of the unanswered questions. Furthermore, emphasis is made on the regular follow-up of these patients to prevent the development of therapy-related complications.
Basaria, S. & Dobs, A.S. (1999). Risks versus benefits of testosterone therapy in elderly men [Electronic version]. Drugs & Aging, 15(2), 131-142. Retrieved September 14, 2005.

The Influence of Growth Hormone (GH) Deficiency and GH Replacement on Quality of Life in GH-Deficient Patients.pdf

According to this study, in contrast to virtually all aspects of metabolism, QOL is difficult to measure. Only recently have tests been developed to assess general QOL, whereas specific tests address those aspects of QOL affected only in specific situations or disease states.
Deijen, J.B. & van der Veen, E.A. (1999). The influence of growth hormone (GH) deficiency and GH replacement on quality of life in GH-deficient patients [Electronic version]. Journal of Endocrinological Investigation, 22(5 Suppl.), 127-136. Retrieved January 18, 2006.

The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients.pdf

This study concluded that GH treatment for 10 yr in GHD adults resulted in increased lean body and muscle mass, a less atherogenic lipid profile, reduced carotid intima media thickness, and improved psychological well-being.
Gibney, J., Wallace, J.D., Spinks, T., Schnorr, L., Ranicar, A., Cuneo, R.C., et al. (1999). The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 84(8), 2596-2602. Retrieved January 25, 2006.

Perioperative Growth Hormone Treatment and Functional Outcome After Major Abdominal Surgery: A Randomized, Double-Blind, Controlled Study.pdf

This study concluded that perioperative hGH treatment of younger patients undergoing major abdominal surgery preserved limb lean tissue mass, increased postoperative muscular strength, and reduced long-term postoperative fatigue.
Kissmeyer-Nielsen, P., Jensen, M.B. & Laurberg, S. (1999). Perioperative growth hormone treatment and functional outcome after major abdominal surgery: a randomized, double-blind, controlled study [Electronic version]. Annals of Surgery, 229(2), 298-302. Retrieved January 25, 2006.

Plasma Polyphenols and Antioxidants, Oxidative DNA Damage and Endothelial Function in a Diet and Wine Intervention Study in Humans.pdf

An intervention study was performed to evaluate the influence of a Mediterranean diet, a high fat diet, and their supplementation with red wine in moderate amounts, on biochemical, physiological, and clinical parameters related to atherosclerosis and other chronic diseases. The results presented support the following conclusions: a high fat diet induces oxidative stress; a diet rich in fruits and vegetables enhances antioxidant defenses; wine supplementation to a high fat or a Mediterranean diet increases plasma antioxidant capacity, decreases oxidative DNA damage, and normalizes endothelial function.
Leighton, F., Cuevas, A., Guasch, V., Perez, D.D., Strobel, P., San Martin, A., et al. (1999). Plasma polyphenols and antioxidants, oxidative DNA damage and endothelial function in a diet and wine intervention study in humans [Electronic version]. Drugs Under Experimental and Clinical Research, 25(2-3), 133-141. Retrieved November 1, 2005.

Procoagulant Activity and Cytokine Expression in Whole Blood Cultures from Patients with Atherosclerosis Supplemented with Omega-3 Fatty Acids.pdf

The present results from this study indicate a reduction in pro-thrombotic potential in patients receiving highly concentrated n-3 FA, whereas some proinflammatory responses might be adverse.
Seljeflot, I., Johansen, O., Arnesen, H., Eggesbo, J.B., Westvik, A.B., et al. (1999). Procoagulant activity and cytokine expression in whole blood cultures from patients with atherosclerosis supplemented with omega-3 fatty acids [Electronic version]. Thrombosis and Haemostasis, 81(4), 566-570. Retrieved September 16, 2005.

Growth Hormone Therapy in Adults and Children.pdf

According to this study, the goals of growth hormone therapy in adults is to restore normal body composition, improve muscle and cardiac function, normalize serum lipid concentrations, and improve the quality of life.
Vance, M.L. & Mauras, N. (1999). Growth hormone therapy in adults and children [Electronic version]. The New England Journal of Medicine, 341(16), 1206-1216. Retrieved January 25, 2006.

Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review.pdf

The importance of GH throughout adult life is now unequivocally accepted.  GH deficiency is recognized to result in alterations in body composition, physical performance, psychological well-being, and substrate metabolism.  Many of these alterations can be improved or corrected with GH replacement.  The prospect of GH replacement becoming routine, however, does raise a number of issues.
Carroll, P.V., Christ, E.R., Bengtsson, B.A., Carlsson, L., Christiansen, J.S., et al.  (1998). Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review [Electronic version]. The Journal of Clinical Endocrinology & Metabolism, 83(2), 382-395. Retrieved May 17, 2005.

Serum Free and Total Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-1 and Insulin-Like Growth Factor Binding Protein-3 Levels in Healthy Elderly Individuals.pdf

This study concluded that low free IGF-I and high IGFBP-1 levels are associated with a decreased self-reported quality of health, but are not related to physical disability in the elderly.
Janssen, J.A., Stolk, R.P., Pols, H.A., Grobbee, D.E. & Lamberts, S.W. (1998). Serum free and total insulin-like growth factor-I, insulin-like growth factor binding protein-1 and insulin-like growth factor binding protein-3 levels in healthy elderly individuals. Relation to self-reported quality of health and disability [Electronic version]. Gerontology, 44(5), 277-280. Retrieved January 19, 2006.

Choice of Cooking Oils--Myths and Realities.pdf

This article discusses how the newer "heart-friendly" oils like sunflower or safflower oils possess undesirable PUFA content and there are numerous research data now available to indicate that the sole use or excess intake of these newer vegetable oils are actually detrimental to health and switching to a combination of different types of fats including the traditional cooking fats like ghee, coconut oil and mustard oil would actually reduce the risk of dyslipidaemias, AHD and Type-2 DM.
Sircar, S. & Kansra, U. (1998). Choice of cooking oils--myths and realities [Electronic version]. Journal of the Indian Medical Association, 96(10), 304-307. Retrieved November 1, 2005.

Postmenopausal Hormone Therapy. Is it Useful for Coronary Prevention?.pdf

This article states that because about one of two U.S. women die from cardiovascular disease (heart disease and stroke), emphasis is warranted on available data, which suggest that the group of women likely to experience the greatest cardioprotection from hormone therapy are those with defined coronary disease or those at high risk for occurrence; the group of women least likely to benefit are those at increased risk for breast cancer
Wenger, N.K. (1998). Postmenopausal hormone therapy. Is it useful for coronary prevention? [Electronic version]. Cardiology Clinics, 16(1), 17-25. Retrieved October 3, 2005.

Two Years of Replacement Therapy in Adults with Growth Hormone Deficiency.pdf

A large group of human growth hormone (hGH) deficient adults received human growth hormone (hGH) replacement therapy for two years.  The study confirmed that human growth hormone (hGH) supplementation and modulation created beneficial effects on body composition, metabolic parameters and improvement on a general sense of well-being.
Verhelst, J., Abs, R., Vandeweghe, M., Mockel, J., Legros, J.J., Copinschi, G., et al. (1997). Two years of replacement therapy in adults with growth hormone deficiency [Electronic version]. Clinical Endocrinology (Oxford), 47(4), 485-494. Retrieved July 25, 2003.

Outcomes of Long-Term Testosterone Replacement in Older Hypogonadal Males: A Retrospective Analysis.pdf

This study concluded that testosterone replacement therapy appears to be well tolerated by over 84% of the subjects. Long term testosterone replacement to date appears to be a safe and effective means of treating hypogonadal elderly males, provided that frequent follow-up blood tests and examinations are performed.
Hajjar, R.R., Kaiser, F.E. & Morley, J.E. (1997). Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 82(11), 3793-3796. Retrieved January 25, 2006.

DHEA: A Biologist's Perspective.pdf

According to the author, it has been proposed that replacement therapy with DHEA to restore youthful levels of DHEAS in older individuals might have beneficial effects on a variety of age-related conditions, such as cardiovascular and neoplastic diseases, diabetes, immune dysfunction, muscular weakness, and depression.
Hornsby, P.J. (1997). DHEA: a biologist's perspective [Electronic version]. Journal of the American Geriatrics Society, 45(11), 1395-1401. Retrieved January 19, 2006.